Dr. Schon, Neymeyr & Partner Patentanwalte Mbb Analysis

LAW FIRM ANALYSIS

Latest European patent oppositions filed by Dr. Schon, Neymeyr & Partner Patentanwalte Mbb

Patent:
Title:
New Use
Applicant:
Opposition Date:
2024-07-10
Patent:
Title:
Pharmaceutical Formulations Containing Dapagliflozin Propylene Glycol Hydrate
Opposition Date:
2024-02-09
Patent:
Title:
Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure
Applicant:
Opposition Date:
2023-11-30
Patent:
Title:
Pharmaceutical Compositions Based On Superstructures Of Angiotensin Receptor Antagonist/Blocker (Arb) And Neutral Endopeptidase (Nep) Inhibitor
Applicant:
Opposition Date:
2023-08-24
Patent:
Title:
Driverless Transport System
Opposition Date:
2023-06-06
Patent:
Title:
Device And Method For Detecting Errors In Machines
Applicant:
Opposition Date:
2023-05-17
Patent:
Title:
Semaglutide In Cardiovascular Conditions
Opposition Date:
2023-05-10
Patent:
Title:
Compositions And Uses For Treating Multiple Sclerosis
Applicant:
Opposition Date:
2023-04-20
Patent:
Title:
Method For Maintenance Of An Automated Conveyor System And Conveyor System
Opposition Date:
2023-04-19
Patent:
Title:
S1P Receptor Modulators For Treating Multiple Sclerosis
Applicant:
Opposition Date:
2023-01-23